Meanwhile, the expression of LAG3 and TIGIT in this group is relatively high, combined with higher tumor mutation burden (TMB) and microsatellite instability (MSI), which suggests a better response to immune checkpoint inhibitors.28 This evidence concerns the gene LAG3 and neoplasm.